US 11530255
Human antibodies to Ebola virus glycoprotein
granted A61KA61K2039/507A61K39/3955
Quick answer
US patent 11530255 (Human antibodies to Ebola virus glycoprotein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/507, A61K39/3955, A61P, A61P31/14